Please login to the form below

Not currently logged in
Email:
Password:

vaccine trials

This page shows the latest vaccine trials news and features for those working in and with pharma, biotech and healthcare.

Study finds mixed vaccine schedules provide strong immune response against COVID-19

Study finds mixed vaccine schedules provide strong immune response against COVID-19

And AZ's Vaxzevria COVID-19 vaccine shows strong immune responses following a delayed second dose. ... added. AZ reveals new data for its Vaxzevria COVID-19 vaccine. AZ has also revealed new data from a sub-analysis of two Oxford University-led trials,

Latest news

More from news
Approximately 0 fully matching, plus 128 partially matching documents found.

Latest Intelligence

  • Fair representation in research matters to the sector and to society Fair representation in research matters to the sector and to society

    In the US, both Pfizer and Moderna worked with community organisations to increase representation in the COVID-19 vaccine trials. ... Community organisations can play a critical role improving representation in health research and trials.

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    Not just for the COVID-19 programmes, but for every other vaccine made these days. ... no large-scale clinical trials having been completed, caused widespread concern among the scientific community.

  • Multilingual remote conferencing and interpreting platforms in the era of COVID-19 Multilingual remote conferencing and interpreting platforms in the era of COVID-19

    In April this year there were 650 groups around the world carrying out 460 different coronavirus vaccine trials on hundreds of thousands of individuals from different nationalities. ... will lead to even greater engagement with medical and clinical

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    Pharma giant Johnson &Johnson is also at the forefront of developing a COVID-19 vaccine, having said it plans to start clinical trials of its lead candidate in September. ... Researchers from Oxford University have also said they plan to start clinical

  • Deal Watch September 2016 Deal Watch September 2016

    Celgene will be responsible for development costs for all indications from phase II clinical trials and beyond. ... Moderna Therapeutics has received $8m of the grant to fund early-stage trials of the vaccine and plans to submit an investigational new

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Andrew Gengos joins ImmunoCellular as CEO Andrew Gengos joins ImmunoCellular as CEO

    Will lead company as it initiates phase II trials investigating brain tumour vaccine. ... Gengos joins at an important time for ImmunoCellular, with the company having recently commenced a phase II trial investigating its lead product candidate ICT-107,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...